Skip to main content
. Author manuscript; available in PMC: 2019 Feb 21.
Published in final edited form as: Neuroscience. 2018 Jan 6;372:225–236. doi: 10.1016/j.neuroscience.2017.12.048

Figure 6. Effects of CXCL1 on body weight changes following L5Tx in WT mice.

Figure 6

WT mice were randomly divided into the following 4 treatment groups: no i.t. injection, saline i.t. injection, and recombinant mouse CXCL1 (at 1 ng/5 µl/mouse or 10 ng/5 µl/mouse) i.t. injections. Injections were given daily from day 6–13 post-L5Tx. Body weight of all animals were monitored from before the initiation of the experiment (baselines) until the end of the experiment, day 20 post-L5Tx. Data are shown in males (A) and females (B) separately due to that the initial statistical analysis suggested sex differences (mean ± SEM, n = 6). # p < 0.05 between the saline group and the high dose CXCL1 (10 ng /5 µl) group, and ** p < 0.05, * p < 0.1 compared to “no injection” group.